Acurx Pharmaceuticals (ACXP) Stock Price, Quote, News & History | Benzinga

Acurx Pharmaceuticals Inc (ACXP) Stock Price, Quote, News & History

ACXPNASDAQ

Trade with Public

Trade with Public

$1.57

0.1812.69%

Last update: Aug 17, 3:37 PM

PRO

Why Is It Moving?™:Acurx Pharmaceuticals shares are trading higher after the company announced...

Earnings: Q2 2026 Earnings were released on Fri Aug 14th, before the market open

Conference Call: The most recent conference call started at 8:00 AM, 3 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$1.40

Close

-

Volume / Avg.

1.06M / 103.62K

Day Range

$1.39 - $1.82

52 Wk Range

1.31 - 8.34

Market Cap

$6.76M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

3.07%

Days to Cover

1.79

Recent Acurx Pharmaceuticals Inc News

Crude Oil Gains Over 2%; PepsiCo Posts Upbeat Q1 Earnings

Avi Kapoor

Dow Surges Over 100 Points; US Initial Jobless Claims Fall

U.S. stocks higher, Dow up 100 points. NASDAQ and S&P 500 also see gains. Energy shares up, consumer discretionary down. Initial jobless claims decline.

Avi Kapoor

What's Going On With Acurx Pharmaceuticals Stock Today?

Acurx Pharmaceuticals (NASDAQ:ACXP) shares down on Friday after reporting net loss for Q4 2025, but with positive cash and $1.5M raised.

Nabaparna Bhattacharya

Why Is Acurx Pharmaceuticals Stock Falling Thursday?

ACXP shares are falling Thursday as overbought signals trigger a pullback after Wednesday's 108% rally. Read the full clinical update.

Kaustubh Bagalkote

Why Petco Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Petco Health and Wellness (WOOF) reported strong Q4 sales, but missed earnings estimates. Other gainers include TLYS, LSF, CDXS, TURB, WGRX, BMBL, LWLG, ABVX, and BATL. Losers include NTSK, GSUN, VSA, and TANH.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-6.14M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

10.75M

Free Cash Flow (TTM)

-6.14M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

4.61M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$3.26M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.85

Earnings Yield % (TTM)

-271.68%

Earnings Yield % (FWD)

-143.37%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.63

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$9.25M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.40

Close

-

Volume / Avg.

1.06M / 103.62K

Day Range

$1.39 - $1.82

52 Wk Range

1.31 - 8.34

Market Cap

$6.76M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

3.07%

Days to Cover

1.79

About

Sector

Health Care

Industry

Biotechnology

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive sel...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Acurx Pharmaceuticals (ACXP) stock?

A

You can purchase shares of Acurx Pharmaceuticals (NASDAQ:ACXP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Acurx Pharmaceuticals (ACXP) competitors?

A

Other companies in Acurx Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Acurx Pharmaceuticals (ACXP) stock?

A

Acurx Pharmaceuticals has a consensus price target of $17.00.

Q

What is the current price for Acurx Pharmaceuticals (ACXP)?

A

The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.572 last updated August 17, 2026 at 3:37 PM EDT.

Q

Does Acurx Pharmaceuticals (ACXP) pay a dividend?

A

There are no upcoming dividends for Acurx Pharmaceuticals.

Q

When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?

A

Acurx Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Acurx Pharmaceuticals (ACXP) going to split?

A

There is no upcoming split for Acurx Pharmaceuticals.

Q

What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?

A

Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.